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Human respiratory syncytial virus (HRSV) is the leading cause of serious pediatric acute respiratory tract
infections, and a better understanding is needed of the host response to HRSV and its attenuated vaccine
derivatives. It has been shown previously that HRSV nonstructural proteins 1 and 2 (NS1 and NS2) inhibit the
induction of alpha/beta interferon (IFN-/) in A549 cells and human macrophages. Two principal transcrip-
tion factors for the early IFN- and -1 response are interferon regulatory factor 3 (IRF-3) and nuclear factor
B (NF-B). At early times postinfection, wild-type HRSV and the NS1/NS2 deletion mutants were very similar
in the ability to activate IRF-3. However, once NS1 and NS2 were expressed significantly, they acted cooper-
atively to suppress activation and nuclear translocation of IRF-3. Since these viruses differed greatly in the
induction of IFN-/, NF-B activation was evaluated in Vero cells, which lack the structural genes for
IFN-/ and would preclude confounding effects of IFN-/. This showed that deletion of the NS2 gene sharply
reduced the ability of HRSV to induce activation of NF-B. Since recombinant HRSVs from which the NS1 or
NS2 genes have been deleted are being developed as vaccine candidates, we investigated whether the changes
in activation of host transcription factors and increased IFN-/ production had an effect on the epithelial
production of proinflammatory factors. Viruses lacking NS1 and/or NS2 stimulated modestly lower production
of RANTES (Regulated on Activation Normal T-cell Expressed and Secreted), interleukin 8, and tumor
necrosis factor alpha compared to wild-type recombinant RSV, supporting their use as attenuated vaccine
candidates.
Human respiratory syncytial virus (HRSV) is the most com-
mon cause of viral bronchiolitis and pneumonia in infants and
children worldwide. HRSV is an enveloped, nonsegmented,
negative-strand RNA virus that belongs to the genus Pneumo-
virus of the family Paramyxoviridae (7). Pneumoviruses express
two putative nonstructural proteins, NS1 and NS2, from sep-
arate mRNAs encoded by the first two genes in the viral gene
order. Recombinant HRSVs in which the NS1 and/or NS2
genes have been deleted (NS1, NS2, and NS1/2) exhibit
reduced replication in cultured cells that are competent to
produce alpha/beta interferon (IFN-/), as well as in mice,
monkeys, and chimpanzees (15, 16, 33, 34, 38). HRSVs lacking
the NS1 and NS2 genes induced high levels of IFN-/ in a
human pulmonary epithelial cell line (A549) and in monocyte-
derived macrophages (31). The NS1 and NS2 proteins of bo-
vine RSV (BRSV) also had been previously shown to suppress
the induction of IFN-/ and have been shown to suppress the
IFN-mediated antiviral state (5, 6, 27, 28, 37).
IFN-/ are secreted by most eukaryotic cells in order to
establish a first line of defense against viral infection. In human
cells, the IFN response commences with the production of
IFN- and -1, which then induce approximately a dozen other
IFN-s and additional amounts of IFN- and -1 in an auto-
crine and paracrine manner. IFN- is induced at the level of
transcription initiation by a number of regulatory factors. The
key inducers of IFN- are interferon regulatory factor 3
(IRF-3) and nuclear factor B (NF-B). Activator protein 1
(AP-1), a heterodimer of ATF-2 and c-jun, is a universal tran-
scription factor that also plays a role in the induction of IFN-.
These three transcription factors can be activated by double-
stranded RNA (dsRNA), among other inducers. Once acti-
vated, they form a transcriptional enhancer complex, called an
enhanceosome, and bind to the IFN- promoter (13). The
IFN- promoter is composed of an overlapping set of positive
regulatory domains (PRDs) I to IV. IRF-3 binds to PRDs I and
III, while NF-B binds to PRD II and AP-1 to PRD IV. The
IFN-1 promoter contains virus response elements that resem-
ble PRDs I and III of the IFN- promoter (1).
IRF-3 is expressed constitutively in the cytoplasm and is
activated by phosphorylation on serine and threonine residues
in the C-terminal region mediated by kinases that are activated
in response to viral dsRNA and viral nucleocapsid protein or
nucleocapsid-like structures (9, 29, 35). This results in the
formation of IRF-3 dimers that associate with the coactivators
p300 and CBP and are translocated to the nucleus, where they
bind to the IFN- promoter (39). Activated IRF-3 also can
directly up-regulate transcription of additional genes, such as
the proinflammatory chemokine RANTES (regulated on acti-
vation normal T-cell expressed and secreted) (22). A number
of viruses have been shown to encode proteins that interfere
with activation of IRF-3, including Bunyamwera (18), influ-
enza A (32), and Ebola (2) viruses. Recently, the NS1 and NS2
proteins of BRSV were implicated in inhibiting phosphoryla-
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tion of IRF-3 (6). Here, we investigate the effects of the indi-
vidual proteins of HRSV on IRF-3 translocation and show that
the effect is time dependent.
In addition to its role in inducing IFN-/, NF-B plays a
role in the expression of a wide range of genes involved in
inflammation and innate and adaptive immunity (20, 36). In-
active NF-B is sequestered in the cytoplasm by association
with the IB regulatory proteins. In response to various induc-
ers, such as dsRNA, cytokines, lipopolysaccharides, and IFN-
/, a cascade of kinases is activated, resulting in the phos-
phorylation of IB and release of NF-B, which is then
translocated to the nucleus. The IB proteins repress or sus-
tain NF-B function by controlling its trafficking between the
cytoplasm and nucleus (20). The main activated form of NF-B
is a heterodimer of p50 and p65, which is persistently activated
during infection of cultured cells with HRSV (3, 8, 12). Here,
we have examined the activation of NF-B in Vero cells, which
lack the structural genes for IFN-/, in order to avoid the
complication of autocrine effects of IFN-/. Under these con-
ditions, the HRSV NS2 protein appeared to play the major
role in stimulating activation of NF-B. AP-1 was not signifi-
cantly activated by infection with either wild-type (wt) HRSV
or the NS1/NS2 mutants.
In addition to IFN-/, IRF-3 and NF-B bind to the tran-
scription promoters of numerous proinflammatory cytokines.
As a measure of the overall impact of NS1 and NS2 on the
epithelial cell response to HRSV, we measured the production
of three factors: the CC chemokine RANTES, the CXC che-
mokine interleukin-8 (IL-8), and the cytokine tumor necrosis
factor alpha (TNF-). Understanding the role of the NS pro-
teins in altering the cellular response to infection is important
in understanding the basis of attenuation of live RSV vaccines
in which these proteins have been ablated.
MATERIALS AND METHODS
Cells and viruses. Vero and A549 cells were maintained in Opti-MEM sup-
plemented with 4% fetal calf serum. The recombinant RSVs (rRSVs) NS1,
NS2, and NS1/2 were constructed in previous work and are derivatives of the
wt A2 strain (wt rRSV) (31, 33, 34, 38). All of the viruses were grown in Vero
cells, which lack the structural genes for IFN-/, and purified by centrifugation
and banding in discontinuous 30 to 60% (wt/vol) sucrose gradients. The identity
(presence of the desired mutation) and purity (absence of cross-contamination)
of the specific virus stocks were confirmed by reverse transcription-PCR.
Infections. Vero and A549 cells were infected at an input multiplicity of
infection (MOI) of 3 PFU per cell for all experiments except for those using
luciferase reporter plasmids, where the MOI was 1. Cells were mock infected or
infected with wt rRSV, NS1, NS2, NS1/2, or UV-inactivated wt rRSV in
serum-free Opti-MEM for 2 h. The cells were then washed with serum-free
Opti-MEM, which was replaced with Opti-MEM/2% fetal bovine serum/antibi-
otics, and incubated at 37°C.
Transfections and reporter assays. As a positive control for IRF-3, NF-B,
and AP-1 activation, cells were transfected with 12 g per 106 cells of polypoly(I:C)
(Amersham Biosciences) using Lipofectamine (Invitrogen) in serum-free Opti-
MEM for 2 h, after which the polypoly(I:C) was replaced with medium contain-
ing 2% fetal bovine serum and antibiotics.
IRF-3 activity was assayed using p55CIBLuc, in which the luciferase gene is
under the control of the PRD I element of the IFN- promoter (a generous gift
from Takashi Fujita, Kyoto, Japan) (39). AP-1 and NF-B activities were assayed
using pAP-1-Luc and pNF-B-Luc reporter plasmids, which contain promoter
elements responsive to activity of the respective factors (Stratagene Pathdetect
cis-reporting systems). As a positive control for luciferase activation, the IRF-3,
NF-B, and AP-1 reporter plasmids were cotransfected with the expression
vector of a known activator, MEK kinase (pFC-MEKK; Stratagene; not shown).
Subconfluent A549 and Vero cells grown in 12-well plates were transfected with
0.5 g of vector using FuGENE 6 (Roche) in serum-free Opti-MEM. Ten hours
after transfection with the reporter plasmids, cells were either mock infected or
infected with wt rRSV, NS1, NS2, or NS1/2 at an MOI of 1 as described
above. At 8 or 14 h postinfection (p.i.), the cells were lysed directly in the wells
with cell lysis buffer (25 mM Tris-phosphate [pH 7.8], 2 mM dithiothreitol, 2 mM
1,2-diaminocyclohexane-N,N,N,N-tetraacetic acid, 10% glycerol, 1% Triton
X-100) and clarified by centrifugation. Luciferase activity was measured with a
commercial assay buffer (Promega) and a luminometer (Turner TD-20e).
Immunofluorescence. Vero or A549 cells were grown on circular coverslips
and were mock infected or infected as described above. At the indicated times
p.i., the coverslips were washed with phosphate-buffered saline (PBS) and fixed
with 2% paraformaldehyde in PBS (Electron Microscopy Sciences). The cells
were blocked with PBS/5% bovine serum albumin (BSA), permeabilized with 1%
Triton X-100 in PBS/3% BSA, and incubated for 1.5 h at 32°C with one of the
following primary antibodies: rabbit anti-IRF-3 (Santa Cruz), diluted 1:500 in
PBS/3% BSA; mouse anti-NF-B (p65; Santa Cruz), diluted 1:200 in PBS/3%
BSA; or rabbit antiserum against the C terminus of NS2, which cross-reacts with
NS1 due to partial sequence identity in the peptide region, diluted 1:1,500 in
PBS/3% BSA. After primary-antibody incubation, the cells were washed once
with 1% Triton X-100 in PBS/3% BSA and twice with PBS. Secondary antibodies
(anti-rabbit antibodies tagged with AF488 for IRF-3, anti-mouse-AF488 for
NF-B, and anti-rabbit-AF594 for NS1/NS2; Molecular Probes) were diluted
1:1,000 in PBS/3% BSA, and the cells were incubated for 1.5 h at 32°C. The cells
were washed with 1% Triton X-100 in PBS/3% BSA and then twice with PBS and
stained with 1 g/ml DAPI (4,6-diamidino-2-phenylindole) in PBS. The per-
centage of cells in which NF-B or IRF-3 were brightly stained in the nucleus, or
in which NS1 and/or NS2 was brightly stained, was calculated using 10 fields of
view from two independent experiments, with DAPI-stained nuclei representing
the total number of cells per field of view.
Preparation of subcellular extracts. Nuclear and cytosolic fractions of A549
cells and Vero cells were prepared using methods modified from those of Tian
et al. (36). The cells were washed in PBS and lysed by the addition of 3 cell
volumes of buffer A, which contained 50 mM HEPES (pH 7.4), 10 mM KCl, 1
mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 0.1 mg/ml of phenylmethylsul-
fonyl fluoride, 1 g/ml of pepstatin A, 1 g/ml of leupeptin, 10 g/ml of soybean
trypsin inhibitor, 10 g/ml of aprotinin, and 0.5% IGEPAL CA-630 ([octylphe-
noxy] polyethoxyethanol). After 20 min on ice, the nuclei were pelleted by
centrifugation at 6,000  g for 20 min at 4°C. The supernatant constituted the
cytosolic fraction. The nuclear pellet was washed in buffer A to remove traces of
the cytosol. Proteins in the nuclei were extracted by incubation in buffer C, which
contained 10% glycerol, 50 mM HEPES (pH 7.4), 400 mM KCl, 1 mM EDTA,
1 mM EGTA, 1 mM dithiothreitol, 0.1 mg/ml of phenylmethylsulfonyl fluoride,
1 g/ml of pepstatin A, 1 g/ml of leupeptin, 10 g/ml of soybean trypsin
inhibitor, and 10 g/ml of aprotinin. After 30 min on ice with frequent vortexing,
the nuclear protein extract was clarified by centrifugation at 12,000  g for 30
min at 4°C. The protein content was determined with a Pierce bicinchoninic acid
protein assay kit using BSA as a standard: from a given number of cells, the
cytosolic fraction contained 	4-fold more protein than the nuclear fraction. The
efficacy of nuclear/cytosol separation was confirmed in each experiment by West-
ern blot analysis using specific markers described below.
Western blot analysis. For analysis of nuclear and cytoplasmic fractions, 90 g
of protein from each sample was heated at 95°C for 2 min in commercially
obtained lithium dodecyl sulfate sample buffer (Invitrogen) that contained 1%
(wt/vol) sodium dodecyl sulfate (SDS) supplemented with 100 mM dithiothreitol.
The proteins were separated by electrophoresis on 12% polyacrylamide gels in
the presence of SDS (12% SDS-polyacrylamide gel electrophoresis ) using com-
mercially obtained precast gels that employed a Bis-Tris buffer system (Invitro-
gen), and transferred to polyvinylidene diflouride membranes in transfer buffer
(NuPAGE; Invitrogen). The membranes were blocked in PBS containing 5%
(wt/vol) dry skim milk for 1 h and immunoblotted with antibodies to either (i)
USF2, as a marker for the nuclear fraction (Santa Cruz); (ii) -tubulin, as a
marker for the cytoplasmic fraction (Santa Cruz); (iii) RSV NS1/NS2 (polyclonal
antibody described above); or (iv) NF-B p65 (Santa Cruz). Bound antibodies
were visualized by incubation with horseradish peroxidase-coupled goat anti-
rabbit or anti-mouse immunoglobulin G antibodies and chemiluminescence
(Pierce).
For analysis of RSV protein expression, infected cell pellets were heated in
lithium dodecyl sulfate sample buffer (Invitrogen) as described above and cen-
trifuged through Qiashredders (QIAGEN). Approximately 3.75 105 cell equiv-
alents of each sample were separated by SDS-PAGE on commercially obtained
4 to 12% gradient gels in a Bis-Tris buffer system (Invitrogen), transferred to
polyvinylidene diflouride membranes, and blocked as described above. The
membranes were incubated with rabbit polyclonal antisera to RSV that had been
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purified by banding at the interface of a 30% to 60% (wt/vol) sucrose gradient.
Bound antibodies were visualized as described above.
ELISA. The secretion of IL-8, RANTES, and TNF- from A549 cells was
quantified by antigen capture enzyme-linked immunosorbent assay (ELISA;
Biosource). Cell culture supernatants collected 16 h and 20 h p.i. were tested
according to the manufacturers directions using controls supplied by the manu-
facturer as standards.
RESULTS
Kinetics of IRF-3 activation and deactivation. Indirect im-
munofluorescence was used to monitor activation and translo-
cation of the transcription factor IRF-3 to the nuclei of A549
cells during infection with wt rRSV, UV-inactivated wt rRSV,
and the NS1, NS2, and NS1/2 gene deletion mutants (Fig.
1A and B). As a positive control, cells were transfected in
parallel with polypoly(I:C) dsRNA. This positive control in-
duced rapid, efficient translocation of IRF-3 to the nucleus,
with peak accumulation at 4 to 6 h posttransfection (Fig. 1A,
bottom). This was followed by the rapid loss of nuclear IRF-3,
reflecting deactivation of IRF-3 and recycling to the cytoplasm,
followed by degradation.
Infection with wt rRSV and the NS1, NS2, and NS1/2
gene deletion mutants efficiently induced nuclear translocation
of IRF-3 during the first 10 h p.i. (Fig. 1A and B). Transloca-
tion of IRF-3 was not observed when cells were exposed to
UV-inactivated wt rRSV, indicating that RSV replication was
necessary for IRF-3 activation in A549 cells (Fig. 1A). In cells
infected with wt rRSV, the average percentage of nuclei pos-
itive for IRF-3 reached a peak of 	26% at 10 h p.i., a value
very similar to the peak of 35% observed with polypoly(I:C)
(Fig. 1B). One difference was that the peak of nuclear accu-
mulation of IRF-3 in response to wt rRSV occurred somewhat
later than in response to polypoly(I:C) (10 h versus 4 to 6 h),
which presumably reflects a lag necessary for viral macromo-
lecular synthesis to occur sufficient to activate IRF-3. The
percentage of cells with intense nuclear IRF-3 staining then
dropped dramatically in wt rRSV-infected cells to 	1% at 14 h
p.i., mirroring the export and degradation of IRF-3 as observed
following treatment with polypoly(I:C). In cells infected with
the NS1/NS2 deletion mutants, the percentage of nuclei posi-
tive for IRF-3 reached a maximum of 	35% by 10 h (NS1) or
	30% by 14 h (NS2, NS1/2) p.i. These values did not sub-
sequently decline, indicating that IRF-3 activation continued in
cells infected with the gene deletion mutants. Thus, the differ-
ence between wt rRSV and the NS1/NS2 gene deletion mu-
tants was not in the ability to activate IRF-3, but rather in the
duration of the response. The ability of NS1 and NS2 to indi-
vidually affect the activation of IRF3 had not been investigated
for HRSV or BRSV. Here, deletion of either NS1 or NS2
greatly alleviated the block to activation. This suggested that
the cooperative effect of the two proteins in inhibiting IRF-3
activation is much greater than those of the individual proteins.
The expression of the NS1 and NS2 proteins in parallel
cultures was visualized with a polyclonal antiserum that recog-
nizes both proteins (Fig. 1A). This showed that the expression
of NS1 was readily detectable by 10 h p.i. (illustrated by the
NS2 mutant in Fig. 1A), whereas NS2 was detected less
efficiently (illustrated by the NS1 mutant). The antiserum
used here detects NS1 much more efficiently than NS2, as we
have observed in previous experiments (unpublished data) and
as was confirmed in the present study by Western blot analysis
(e.g., see Fig. 3B). In wt rRSV-infected cells, the percentage of
cells in which expression of NS1 and NS2 was readily detected
increased from 	8% to 27% from 10 to 14 h p.i. (Fig. 1B),
which coincided with the loss of IRF-3 from the nucleus. This
suggests that the de novo synthesis of NS1 and NS2 in wt
rRSV-infected cells reached a sufficient level by 	10 h p.i. to
block further activation and translocation of IRF-3, so that the
normal deactivation pathway led to a rapid depletion of nu-
clear IRF-3.
The effects of NS1 and NS2 on the activation of IRF-3 were
also investigated using a reporter plasmid containing the lucif-
erase gene under the control of an IRF-3-responsive promoter.
At 8 h p.i., there was significant IRF-3-responsive promoter
activity in A549 cells infected with wt rRSV, NS1, NS2, and
NS1/2, with little difference between the various viruses (Fig.
2). However, there was no increase in IRF-3-responsive pro-
moter activity between 8 h and 14 h p.i. in cells infected with wt
rRSV. As luciferase activity is cumulative, this suggests that
transcription from the IRF-3-responsive reporter plasmid had
ceased. In contrast, cells infected with the NS1/NS2 gene de-
letion mutants exhibited a continued increase in IRF-3-respon-
sive promoter activity between 8 h and 14 h p.i. This confirmed
the results from the immunofluorescence study that wt rRSV
and the NS1/NS2 gene deletion mutants each activated IRF-3
efficiently early in infection but that continued activation was
observed only in cells infected by the NS1/NS2 gene deletion
mutants.
We considered the possibility that the continued activation
of IRF-3 in cells infected with the NS1/NS2 gene deletion
mutants might somehow be due to altered kinetics of viral
macromolecular synthesis. However, Western blot analysis of
cell lysates harvested at various times following infection with
wt rRSV or the gene deletion viruses showed that there was
little difference between viruses in the level of accumulation of
the N and P proteins, as markers of RNA replication and gene
expression (Fig. 3A). Furthermore, it was demonstrated in a
previous study (31) that the intracellular accumulations of viral
genomic RNA were similar for wt rRSV and the NS1/2 mu-
tants.
The patterns of immunofluorescence of NS1 and NS2 in
infected cells indicated that the two proteins accumulated sig-
nificantly in the vicinity of the nucleus (Fig. 1A), although the
staining pattern was not clearly indicative of nuclear accumu-
lation compared to that of IRF-3. If nuclear accumulation of
NS1 or NS2 occurred, it raised the possibility that they might
directly affect events in the IRF-3 activation-deactivation cycle
in that compartment. However, fractionation of A549 cells
infected with wt rRSV, NS1, or NS2 showed that in each
case NS1 and NS2 accumulated mostly in the cytoplasm (Fig.
3B).
The NS2 protein is important for activating NF-B. NF-B
can be efficiently activated by a variety of inducers that include
IFN-/, which strongly up-regulates the expression of the
double-stranded-RNA-activated protein kinase PKR (41).
Since wt rRSV and the NS1/NS2 gene deletion mutants vary
considerably in their abilities to induce IFN-/ (31), in par-
ticular with mutants lacking NS1 being capable of inducing a
very high level, we controlled for this variable by investigating
the activation of NF-B in Vero cells, which lack the structural
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FIG. 1. Nuclear localization of IRF-3 in A549 cells in response to infection with wt rRSV or treatment with synthetic polypoly(I:C). (A) A549
cells were mock infected or infected at an MOI of 3 PFU/cell with wt rRSV, NS1, NS2, NS1/2, or the equivalent amount of UV-inactivated
wt rRSV or were transfected with polypoly(I:C), as indicated. The cells were fixed at the indicated times postinfection, permeabilized, and analyzed
by indirect immunofluorescence with polyclonal antibodies to IRF-3 (green) or a polyclonal antiserum that reacts with both NS1 and NS2 (red).
This antiserum detected NS1 more efficiently than NS2 (see the text). (B) The percentage of cells with nuclei positive for IRF-3 or that were
positive for NS1/NS2 at each time point and for each treatment was calculated based on multiple fields of view from two independent experiments.
The indicated (*) value of IRF-3 for the NS1, NS2, or NS1/2 virus was confirmed to be significantly different from that of wt RSV (P 
 9.1
 108, 1.3  107, or 1.6  108, respectively; Student’s t test). The values of IRF-3 at 14 h versus 10 h for wt RSV also were confirmed to be
significantly different (P 
 1.1  108).
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genes for IFN-/. Translocation of NF-B to the nucleus was
monitored by indirect immunofluorescence at various intervals
p.i. using a mouse monoclonal antibody specific to p65 (Fig. 4A
and B), which is the major form activated in response to HRSV
(3). The inactive form of NF-B, which is sequestered in a
complex in the cytoplasm, could be detected as a diffuse stain-
ing pattern at each time point (Fig. 4A). In cells infected with
wt rRSV, NS1, NS2, or NS1/2, nuclear accumulation of
NF-B was evident in each case by 6 h p.i. (Fig. 4A). Unex-
pectedly, however, the level of nuclear accumulation of NF-B
was significantly lower in cells infected with NS2 or NS1/2,
each of which lacks the NS2 gene. Thus, the presence of the
NS2 gene, and presumably expression of its protein, appeared
to be important in the activation of NF-B. However, the effect
was not absolute, since there was a residual level of activation
by the NS2 viruses. This background was dependent on viral
macromolecular synthesis, as indicated by the lack of NF-B
activation by UV-inactivated virus.
The effect of NS2 on the activation of NF-B was also
investigated using a reporter plasmid containing the luciferase
gene under the control of an NF-B-responsive promoter (Fig.
5). This showed that the magnitude of activation of the NF-
B-responsive promoter (measured in this example at 14 h p.i.)
was greatest for cells infected with wt rRSV, was somewhat less
for cells infected with NS1, and was very low for cells that
were mock infected or infected with NS2 or NS1/2.
We also prepared nuclear extracts from the infected Vero
cells at various times and subjected them to Western blot
analysis with an antibody against p65 as an independent
method of monitoring NF-B activation (Fig. 6A). This con-
firmed that the nuclear accumulation of NF-B p65 was sub-
stantially higher in cells infected with wt rRSV or NS1 than in
cells infected with NS2 or NS1/2 and confirmed that some
activation occurred in the absence of NS2. Nuclear extracts
were also analyzed using an antibody to USF2 to confirm the
purity of the extracts (not shown).
In order to rule out the possibility that the low level of
NF-B activation in response to NS2 and NS1/2 might re-
flect reduced kinetics or magnitude of viral RNA replication
and gene expression in Vero cells, Western blot analysis was
used to measure the levels of accumulation of the N and P
proteins as markers for viral RNA synthesis (Fig. 6B). The
accumulation of N protein at 10 h p.i. was somewhat lower for
cells infected with NS1 and NS1/2, reflecting experimental
variability. By 14 h p.i., the accumulations of both N and P
FIG. 2. Activation of IRF-3 monitored using an IRF3-responsive
reporter gene. A549 cells were transfected with p55CIBLuc, a reporter
plasmid containing the luciferase gene under the control of the PRD
I element of the IFN- promoter. Ten hours posttransfection, the cells
were mock infected or infected with the indicated viruses at an MOI of
1 PFU/cell. At 8 and 14 h postinfection, cells were harvested and
assayed for luciferase activity. Relative light units are given as induc-
tion (n-fold) compared to cells that were transfected with the reporter
plasmid but not mock infected or infected. The mean values and
standard errors of three independent infections are shown. The indi-
cated (*) value for the NS1, NS2, or NS1/2 virus was confirmed to
be significantly different from that of wt RSV (P 
 1.6  105, 0.004,
or 2.1  108, respectively; Student’s t test).
FIG. 3. Viral protein expression in A549 cells infected with wt rRSV and the NS1/NS2 gene deletion mutants. (A) Wt rRSV and the NS1/NS2
deletion mutants display comparable levels of gene expression, as illustrated by the levels of N and P proteins. A549 cells were infected with the
indicated viruses at an MOI of 3 PFU/cell and harvested 6 h, 10 h, or 14 h postinfection. Equivalent amounts of the cell lysates were subjected
to SDS-PAGE and Western blot analysis with a polyclonal serum raised against purified RSV virions. The portion of the blot containing the N
and P proteins is shown. (B) NS1 and NS2 are located predominantly in the cytosolic fraction of wt-rRSV-infected A549 cells. Cells were either
mock infected (lanes 1) or infected with wt rRSV (lanes 2), NS1 (lanes 3), or NS2 (lanes 4) at an MOI of 3. The cells were harvested 20 h
postinfection, and nuclear and cytosolic fractions were prepared and analyzed by Western blotting. The nuclear fraction is represented in
fourfold-greater relative concentration than the cytosolic fraction. The efficacy of cell fractionation was confirmed using antibodies to USF2 as a
marker for nuclear content and -tubulin as a marker for cytosolic content. The localization of NS1 and NS2 was identified using a polyclonal
antiserum that reacts with both proteins but with NS1 more efficiently than NS2.
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proteins were similar for wt RSV and the gene deletion mu-
tants.
Lack of activation of AP-1 by wt rRSV, NS1, NS2, or
NS1/2. The activation of the transcription factor AP-1 in
response to infection with wt rRSV and the NS1/NS2 gene
deletion viruses was evaluated in Vero and A549 cells using a
reporter plasmid under the control of an AP-1-responsive pro-
moter (Fig. 7A and B, respectively). As a positive control, cells
were cotransfected with a plasmid expressing the known acti-
vator MEK kinase, which activated AP-1 to a level 120 to 130
times higher than in mock-infected cells, confirming the effi-
ciency of transfection. There was no significant increase in
expression of the AP-1-dependent reporter plasmid in A549 or
Vero cells infected with wt rRSV, NS1, NS2, or NS1/2
compared to mock infection.
Secretion of cytokines from A549 cells infected with the
NS1/NS2 gene deletion mutants. Activation of IRF-3 and
NF-B and the production of IFN-/ led to changes in the
expression of a broad array of cellular genes, including ones
involved in inflammation and innate and adaptive immunity.
FIG. 4. Nuclear localization of NF-B in Vero cells in response to infection with wt rRSV or the NS1/NS2 gene deletion mutants. (A) Vero
cells were mock infected or infected at an MOI of 3 PFU/cell with either wt rRSV, NS1, NS2, NS1/2, or the equivalent amount of
UV-inactivated wt rRSV. The cells were fixed at the indicated times postinfection, permeabilized, and analyzed by immunofluorescence with a
monoclonal antibody against NF-B p65 (green) or a polyclonal antiserum against NS1 and NS2 (red) that reacted more strongly with NS1 than
with NS2. (B) The percentage of cells with nuclei positive for NF-B or that were positive for NS1/NS2 at each time point and for each treatment
was calculated based on multiple fields of view from two independent experiments. The indicated value of NF-B for the NS2 or NS1/2 virus
was confirmed to be significantly different from that of wt RSV at 10 h (*, P 
 5  106 and 5.7  106, respectively; Student’s t test) and at 14 h
(**, P 
 3.3  106 and 2.9  106, respectively). In contrast, the value for the NS1 mutant was not significantly different from that for wt RSV
at each time point.
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The deletion of NS1 and/or NS2 had the potential for unpre-
dictable effects on the epithelial cell response: for example,
since IRF-3 can up-regulate transcription of the RANTES
chemokine (22), vaccine candidates in which NS1 or NS2 have
been deleted might have the potentially undesirable attribute
of increased RANTES expression. We therefore investigated
the expression of three proinflammatory factors by A549 cells
in response to infection with wt rRSV and the NS1/NS2 gene
deletion mutants: the chemokine RANTES, the chemokine
IL-8, and the cytokine TNF-. We chose these factors, as they
have been suggested to contribute to disease in RSV-infected
infants (17, 30). Our goal was not to attempt to dissect the
signaling pathways or determine their relative contributions to
the expression of each cytokine, but rather to determine the
gross effect of the NS1 and NS2 gene deletions on the human
epithelial cell response. ELISA of medium supernatants har-
vested at 16 and 20 h p.i. confirmed the secretion of IL-8,
RANTES, and TNF- in response to wt rRSV (Fig. 8A, B, and
C), as has been previously observed (36, 42). This experiment
showed that the secretion of IL-8, RANTES, and TNF- in
response to the gene deletion mutants was reduced compared
to wt rRSV, providing an indication of safety for these vaccine
candidates.
DISCUSSION
Infection by viruses triggers the activation of host cell sig-
naling pathways, including gene products that contribute to
rapid intracellular defense against infection and influence in-
nate and adaptive immune responses. Type 1 interferons (IFN-
/) are part of this defense and establish an antiviral state
within infected and neighboring cells. The IFN-/ response in
human cells first involves the production of IFN- and -1.
Transcription of IFN- and -1 is mediated by the transcrip-
tion factors IRF-3, NF-B, and AP-1. Once secreted, IFN-
and -1 bind to cell surface receptors in an autocrine and
paracrine fashion. This induces the JAK/STAT signaling path-
way, which produces the full complement of IFN-s, additional
IFN-, and a wide array of interferon-stimulated genes, includ-
ing ones that establish an intracellular antiviral state. IRF-3
and NF-B also directly mediate the transcription of certain
interferon-stimulated genes and other cellular genes with host
FIG. 5. NF-B activation monitored with an NF-B-responsive re-
porter gene. Vero cells were transfected with a luciferase construct
driven by a promoter element responsive to NF-B. Ten hours post-
transfection, the cells were infected with the indicated viruses at an
MOI of 1 PFU/cell. At 14 h postinfection, cells were harvested and
assayed for luciferase activity. Relative light units are given as induc-
tion (n-fold). The results show the mean values and standard errors of
three independent infections. The values for NS2 and NS1/2 were
significantly different from that for wt RSV (*, P 
 6.5  109 and 1.2
 1010, respectively) and NS1 (**, P 
 1.2  105 and 1.2  107,
respectively).
FIG. 6. Western blot analysis of (A) the nuclear accumulation of NF-B p65 and (B) the synthesis of RSV N and P proteins in Vero cells
infected with wt rRSV or the NS1/NS2 gene deletion mutants. (A) Nuclear accumulation of NF-B p65. Cells were mock infected or infected at
an MOI of 3 PFU/cell with either wt rRSV, NS1, NS2, NS1/2, or UV-inactivated wt rRSV. The nuclear fractions from replicate cultures were
harvested at the indicated times, and equivalent amounts of protein were subjected to SDS-PAGE, followed by Western blotting with a monoclonal
antibody against NF-B p65. (B) Expression of RSV N and P proteins. Cells were infected with the indicated viruses and harvested 6 h, 10 h, and
14 h postinfection. Equal amounts of cell extract were subjected to SDS-PAGE and Western blot analysis of RSV N and P proteins using a
polyclonal antiserum to purified virions.
VOL. 79, 2005 RSV NS1 AND NS2 REGULATE IRF-3 AND NF-B 5359
 o
n
 N
ovem
ber 12, 2015 by University of Queensland Library
http://jvi.asm.org/
D
ow
nloaded from
 
defense functions. For example, IRF-3 can directly activate
transcription of the RANTES chemokine (22), and NF-B has
been shown to mediate antiviral protection against HRSV in
an epithelial cell line independently of IFN-/ (4).
Viruses have evolved mechanisms to counteract the IFN-/
response that may involve blocking initial induction, blocking
JAK/STAT signaling, or inhibiting the antiviral state at some
subsequent step (11, 13). We have shown previously (31) that
the NS1 and NS2 proteins of HRSV inhibit the induction of
IFN-/. This had also been shown for the NS1 and NS2
proteins of BRSV, the bovine counterpart of HRSV (5, 6, 28,
37). For each virus, the proteins exerted their inhibitory activ-
ities individually, as well as cooperatively, although the systems
were not exactly parallel in that NS1 played the greater role for
HRSV compared to NS2 for BRSV.
In the present study, we found that wt HRSV resembled the
NS1, NS2, and NS1/2 deletion mutants in the ability to
activate IRF-3 during the first 	10 h of infection. Thereafter,
the activation of IRF-3 was strongly suppressed in wt HRSV-
infected cells, whereas a high level of activation continued in
cells infected with each of the gene deletion mutants. In nor-
mal cells, IRF-3 is present constitutively and is shuttled con-
tinually between the cytoplasm and nucleus but is predomi-
nantly cytoplasmic. In response to an inducer, such as viral
dsRNA, IRF-3 is phosphorylated and nuclear import is in-
creased over nuclear export. However, without continual stim-
ulation, the phosphorylated form is exported from the nucleus
and degraded by the proteosome pathway in the cytoplasm
(21). This cycle of IRF-3 activation and degradation was evi-
dent in the present study using polypoly(I:C), where a strong
activation and subsequent reversal were observed (Fig. 1A and
B). Our interpretation of the loss of nuclear IRF-3 in cells
infected with wt rRSV is that the accumulation of NS1 and
NS2 proteins reached sufficient levels by 	10 h p.i. to block
further activation, whereas the nuclear export and degradation
part of the cycle continued. Studies with BRSV showed that
NS1 and NS2 interfere with IRF-3 activation by blocking its
phosphorylation, although the roles of the individual proteins
were not investigated (6). It is reasonable to anticipate that the
same mechanism holds for HRSV. The present study indicates
that deletion of either NS1 or NS2 provides substantial acti-
vation of IRF-3, indicating that the two proteins function much
more efficiently together than either does individually.
The inhibition of IRF-3 activation is employed by many
viruses to suppress the induction of IFN-/. The V protein of
simian virus 5 (SV5) interferes with both IRF-3 and NF-B
activation, resulting in poor IFN- induction in wt-infected
cells (14, 26). However, unlike HRSV, wt SV5 does not acti-
vate IRF-3 even in the early stages of infection, prior to viral
protein accumulation. HRSV also differs from SV5 in that
NF-B is activated in wt-HRSV-infected cells. This may ex-
plain why wt RSV is a better inducer of IFN-/ than SV5 and
certain other paramyxoviruses (40). The Ebola virus nonstruc-
tural protein VP35 and the NS3/4A protease of hepatitis C
virus also inhibit IFN-/ production by inhibiting IRF-3 phos-
phorylation (2, 10). The herpes simplex virus type 1 protein
ICP0 blocks the activation of both IRF-3 and IRF-7 (23);
however, the mechanism for this remains to be determined.
We also examined the activation of NF-B in response to wt
rRSV and the gene deletion mutants. However, because these
viruses differed greatly in their abilities to induce IFN-/ (31),
and because IFN-/ can augment NF-B activation, these
experiments were performed in Vero cells, which lack the
structural genes for IFN-/. Unexpectedly, we found that
activation of NF-B was substantially lower in cells infected
with NS2 and NS1/2, which each lack the NS2 gene. This
effect could not be attributed to an obvious difference in viral
gene expression. This strongly suggests that NS2 is involved in
NF-B activation in HRSV-infected cells. The fact that this
effect was observed in the context of a permissive HRSV in-
fection, rather than from an individual expressed cDNA, for
example, lends authenticity to the observation. Previously, the
F glycoprotein was shown to activate NF-B in human mono-
cytes through the TLR4 cell surface receptor and CD14 (19).
In the present study, UV-inactivated virus did not stimulate
NF-B activation, suggesting that binding of the virus to the
FIG. 7. AP-1 activation monitored with an AP-1-responsive reporter gene was not detected within 14 h of infection with RSV. (A) Vero cells
or (B) A549 cells were transfected with a luciferase reporter plasmid. Ten hours posttransfection, the cells were mock infected or infected with
the indicated viruses at an MOI of 1 PFU/cell. At 14 h postinfection, cells were harvested and assayed for luciferase activity. Relative light units
are given as induction (n-fold) compared to cells that were transfected with the reporter plasmid but were not infected or mock infected. Results
show the mean values and standard errors of three independent infections.
5360 SPANN ET AL. J. VIROL.
 o
n
 N
ovem
ber 12, 2015 by University of Queensland Library
http://jvi.asm.org/
D
ow
nloaded from
 
epithelial cell and fusion with the plasma membrane were not
sufficient to significantly activate NF-B. Expression of the
HRSV P protein from a transfected plasmid also was reported
to activate NF-B (3). In the present study, a low level of
NF-B activation did occur in response to HRSV infection in
the absence of NS2, and this presumably represents contribu-
tions from dsRNA and the F and P proteins, as well as what-
ever contribution might occur from oxidative stress or other
potential inducers. Clearly, however, the NS2 protein ap-
peared to play a major role.
In the present study we show that AP-1 is not significantly
activated in response to RSV infection in either Vero or A549
cells. The limited responsiveness of AP-1 to viral infection has
also been demonstrated for SV5 (26) and BRSV (6). The
activation of AP-1 in HRSV-infected A549 cells has been
shown to be sensitive to the redox state (24), and it might be
that variability in the reported results represents differences in
the conditions for cell culture. In any event, the constitutive
level of AP-1 activation in our experiments was ample for a
very robust IFN-/ response (31).
There is presently no available licensed HRSV vaccine.
However, live attenuated viruses containing deletion of the
NS1 and/or NS2 genes, among other attenuating mutations,
are under development and appear to be promising candidates
(34, 38). One of the advantages of the NS1/NS2 deletion mu-
tants as vaccine candidates is the promotion of IFN-/ ex-
pression, which can enhance both innate and adaptive immune
responses (31). However, a number of proinflammatory cyto-
kines and chemokines contain NF-B or IRF-3 binding sites in
their promoters (17, 22) and can also be upregulated indirectly
by IFN-/.
The recent use of cDNA and oligonucleotide microarrays
has demonstrated that airway epithelial cells (A549 and pri-
mary small airway epithelial cells) infected with RSV show
increased expression of a number of chemokines, including
I-309, Exodus-1, TARC, RANTES, MCP-1, MDC, MIP-1/,
IL-8, GRO //, ENA-78, I-TAC, and fractalkine (25, 36, 42).
It has also been demonstrated that human infants with RSV
infection and bronchiolitis have increased secretion of IL-8,
MCP-1, TNF-, eotaxin, MIP-1, and RANTES (17, 30). Vac-
cine candidate viruses that stimulate sustained IRF-3 activa-
tion, elevated NF-B levels, and/or elevated IFN-/ produc-
tion have the potential to stimulate increased production of
proinflammatory chemokines and cytokines that have been
hypothesized to contribute to bronchiolitis and airway hyper-
reactivity. However, in the present study, the NS1/NS2 deletion
mutants were found to be associated with reduced, rather than
augmented, production of IL-8, RANTES, and TNF- from
A549 cells. This provides additional support for the develop-
ment of viruses lacking NS1 and/or NS2 as safe live attenuated
vaccines.
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